These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31062329)

  • 1. Diabetes-Related Dementia.
    Hanyu H
    Adv Exp Med Biol; 2019; 1128():147-160. PubMed ID: 31062329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetes mellitus and dementia].
    Hanyu H
    Brain Nerve; 2014 Feb; 66(2):129-34. PubMed ID: 24523311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid and Tau Positron Emission Tomography in Suggested Diabetesrelated Dementia.
    Takenoshita N; Fukasawa R; Ogawa Y; Shimizu S; Umahara T; Ishii K; Shimada H; Higuchi M; Suhara T; Hanyu H
    Curr Alzheimer Res; 2018; 15(11):1062-1069. PubMed ID: 29984653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetes-related dementia].
    Hanyu H
    Nihon Rinsho; 2016 Mar; 74(3):495-8. PubMed ID: 27025093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subgroups of Alzheimer's disease associated with diabetes mellitus based on brain imaging.
    Fukazawa R; Hanyu H; Sato T; Shimizu S; Koyama S; Kanetaka H; Sakurai H; Iwamoto T
    Dement Geriatr Cogn Disord; 2013; 35(5-6):280-90. PubMed ID: 23594859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of diabetes-related dementia: Longitudinal perfusion SPECT and amyloid PET studies.
    Fukasawa R; Hanyu H; Shimizu S; Kanetaka H; Sakurai H; Ishii K
    J Neurol Sci; 2015 Feb; 349(1-2):45-51. PubMed ID: 25573776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral oxidative stress markers in diabetes-related dementia.
    Hatanaka H; Hanyu H; Fukasawa R; Sato T; Shimizu S; Sakurai H
    Geriatr Gerontol Int; 2016 Dec; 16(12):1312-1318. PubMed ID: 26531676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of Clinically Diagnosed Alzheimer's Disease Associated with Diabetes Based on Amyloid and Tau PET Results.
    Takenoshita N; Shimizu S; Kanetaka H; Sakurai H; Suzuki R; Miwa T; Odawara M; Ishii K; Shimada H; Higuchi M; Suhara T; Hanyu H
    J Alzheimers Dis; 2019; 71(1):261-271. PubMed ID: 31356213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiological Mechanisms Linking Type 2 Diabetes and Dementia: Review of Evidence from Clinical, Translational and Epidemiological Research.
    Bello-Chavolla OY; Antonio-Villa NE; Vargas-Vázquez A; Ávila-Funes JA; Aguilar-Salinas CA
    Curr Diabetes Rev; 2019; 15(6):456-470. PubMed ID: 30648514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus and dementia.
    Pasquier F; Boulogne A; Leys D; Fontaine P
    Diabetes Metab; 2006 Nov; 32(5 Pt 1):403-14. PubMed ID: 17110895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased Muscle Strength and Quality in Diabetes-Related Dementia.
    Tsugawa A; Ogawa Y; Takenoshita N; Kaneko Y; Hatanaka H; Jaime E; Fukasawa R; Hanyu H
    Dement Geriatr Cogn Dis Extra; 2017; 7(3):454-462. PubMed ID: 29430248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory glucose profile in diabetes-related dementia.
    Ogawa Y; Shimizu S; Takenoshita N; Kaneko Y; Satoto T; Hanyu H
    Geriatr Gerontol Int; 2019 Apr; 19(4):282-286. PubMed ID: 30665263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (Pre)diabetes, brain aging, and cognition.
    S Roriz-Filho J; Sá-Roriz TM; Rosset I; Camozzato AL; Santos AC; Chaves ML; Moriguti JC; Roriz-Cruz M
    Biochim Biophys Acta; 2009 May; 1792(5):432-43. PubMed ID: 19135149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology and pathophysiology of vascular cognitive impairment. A critical update.
    Jellinger KA
    Panminerva Med; 2004 Dec; 46(4):217-26. PubMed ID: 15876978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes and risk of cognitive impairment and dementia.
    Whitmer RA
    Curr Neurol Neurosci Rep; 2007 Sep; 7(5):373-80. PubMed ID: 17764626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diabetic brain and cognition.
    Riederer P; Korczyn AD; Ali SS; Bajenaru O; Choi MS; Chopp M; Dermanovic-Dobrota V; Grünblatt E; Jellinger KA; Kamal MA; Kamal W; Leszek J; Sheldrick-Michel TM; Mushtaq G; Meglic B; Natovich R; Pirtosek Z; Rakusa M; Salkovic-Petrisic M; Schmidt R; Schmitt A; Sridhar GR; Vécsei L; Wojszel ZB; Yaman H; Zhang ZG; Cukierman-Yaffe T
    J Neural Transm (Vienna); 2017 Nov; 124(11):1431-1454. PubMed ID: 28766040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
    Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
    J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer disease and cerebrovascular pathology: an update.
    Jellinger KA
    J Neural Transm (Vienna); 2002 May; 109(5-6):813-36. PubMed ID: 12111471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological assessment and cerebral vascular disease: the new standards.
    Godefroy O; ; Leclercq C; Bugnicourt JM; Roussel M; Moroni C; Quaglino V; Beaunieux H; Taillia H; Nédélec-Ciceri C; Bonnin C; Thomas-Anterion C; Varvat J; Aboulafia-Brakha T; Assal F
    Rev Neurol (Paris); 2013 Oct; 169(10):779-85. PubMed ID: 23999023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.